Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Diabetes Mellitus, Type 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=6
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=6
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Diabetes+Mellitus%2C+Type+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=6
PubPharm (7.910)
51
App-based Motivational Interviewing and Artificial Intelligence in Diabetes Management : EMPOWERing Patients With Type 2 Diabetes Mellitus (T2DM) in Primary Care Through App-based Motivational Interviewing PLUS Artificial Intelligence Powered Diabetes Management (EMPOWER-PLUS): Randomised Controlled Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
52
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4) : A 40-week Study Comparing the Efficacy and Safety of Once Weekly IcoSema and Daily Insulin Glargine 100 Units/mL in Participants With Type 2 Diabetes Inadequately Controlled on Oral Anti Diabetic Drugs COMBINE 4
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
53
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions : Finerenone Research of Outcomes and Drug Utilization
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
54
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes : Investigation of the Safety and Efficacy of Once Weekly NNC0519-0130 in Participants With Type 2 Diabetes - a Dose Finding Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
55
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes : A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study Evaluating the Efficacy and Safety of HTD1801 in Patients With Type 2 Diabetes Mellitus Who Have Poor Glycemic Control After Dietary and Exercise Interventions
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
56
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin : A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study Evaluating the Efficacy and Safety of HTD1801 in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
57
Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City : COntinuous Glucose Monitoring, Contingency Management, and Motivational InTerviewing for Patients With TypE 2 Diabetes in Kansas City
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
58
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old : A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial With a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg, and Saxagliptin 2.5 and 5 mg in Pediatric Patients With Type 2 Diabetes Mellitus Who Are Between 10 and Below 18 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
59
Empa PASS on Urinary Tract Malignancies : Post-authorisation Safety Study to Assess the Risk of Urinary Tract Malignancies in Relation to Empagliflozin Exposure in Patients With Type 2 Diabetes: a Multi-database European Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
60
Empowering Patients With Chronic Disease Using Profiling and Targeted Feedbacks Delivered Through Wearable Device : Empowering Patients With Chronic Disease Using Profiling and Targeted Feedbacks Delivered Through Wearable Device (EMPOWER)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[791]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Diabetes Mellitus, Type 2
Medienart
7.910
Aufsätze
7.910
E-Artikel
7.910
E-Ressourcen
Zeitschriftentitel
7.910
ClinicalTrials.gov
Thema
Diabetes Mellitus, Type 2
7.909
610
6.573
Study Type: Interventional
5.672
Diabetes Mellitus
5.163
Recruitment Status: Completed
1.297
Study Type: Observational
1.146
Phase: Phase 3
1.116
Medical Condition: Diabetes Mellitus, Type 2
1.077
Medical Condition: Type 2 Diabetes Mellitus
1.028
Phase: Phase 4
937
Recruitment Status: Recruiting
782
Phase: Phase 1
687
Medical Condition: Type 2 Diabetes
657
Phase: Phase 2
503
Recruitment Status: Unknown status
404
Recruitment Status: Terminated
333
Recruitment Status: Active, not recruiting
317
Recruitment Status: Not yet recruiting
307
Medical Condition: Diabetes, Diabetes Mellitus,...
304
Diabetes Mellitus, Type 1
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.573
2020-
4.014
2010-2019
323
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7.910
Englisch
Haven't found what you're looking for?
Wird geladen...